Debra Liebert
Direttore/Membro del Consiglio presso MILESTONE PHARMACEUTICALS INC.
Patrimonio netto: 15 191 $ in data 31/05/2024
Posizioni attive di Debra Liebert
Società | Posizione | Inizio | Fine |
---|---|---|---|
MILESTONE PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 01/06/2015 | - |
Independent Dir/Board Member | 01/06/2015 | - |
Storia della carriera di Debra Liebert
Precedenti posizioni note di Debra Liebert
Società | Posizione | Inizio | Fine |
---|---|---|---|
Merada Therapeutics, Inc. | Fondatore | - | - |
Nanothera Corp. | Fondatore | - | - |
Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Fondatore | - | - |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Fondatore | - | - |
Trega Biosciences, Inc.
Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Corporate Officer/Principal | - | - |
LPL Technologies, Inc.
LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | Corporate Officer/Principal | - | - |
CancerVax Corp. | Corporate Officer/Principal | - | - |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investitore di Private Equity | 04/01/2011 | - |
Formazione di Debra Liebert
Clarion University of Pennsylvania | Undergraduate Degree |
Duquesne University of The Holy Spirit | Graduate Degree |
University of California, Los Angeles | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Canada | 2 |
Posizioni
Founder | 4 |
Corporate Officer/Principal | 3 |
Private Equity Investor | 1 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MILESTONE PHARMACEUTICALS INC. | Health Technology |
Aziende private | 8 |
---|---|
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
CancerVax Corp. | Commercial Services |
LPL Technologies, Inc.
LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | Health Services |
Trega Biosciences, Inc.
Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Health Technology |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Health Technology |
Nanothera Corp. | |
Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Health Technology |
Merada Therapeutics, Inc. |
- Borsa valori
- Insiders
- Debra Liebert
- Esperienza